Showing results (31-40 of 205) with videos related to
Sort By:
Pageof 21
The Journal of Physiology|October 28, 2003
Electrophysiological properties of human mesenchymal stem cellsJürgen F Heubach, Eva M Graf, Judith Leutheuser, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|December 16, 2004
An aqueous extract of the marine sponge Ectyoplasia ferox stimulates L-type Ca2+-current by direct interaction with the Cav1.2 subunitTorsten Christ, Melinda Wüst, Jan Matthes, et al.Current Opinion in Pharmacology|March 18, 2014
Pharmacology of voltage-gated potassium channel Kv1.5--impact on cardiac excitabilityErich Wettwer, Heinrich TerlauInternational Journal of Cardiology|January 15, 2019
DPP10 is a new regulator of Nav1.5 channels in human heartFabian Belau, Katharina Metzner, Torsten Christ, et al.European Journal of Pharmacology|May 10, 2011
Class I/B antiarrhythmic property of ranolazine, a novel antianginal agent, in dog and human cardiac preparationsTamás Szél, István Koncz, Norbert Jost, et al.Canadian Journal of Physiology and Pharmacology|July 13, 2018
Sex differences in cardiac electrophysiologyUrsula RavensNaunyn-Schmiedeberg'S Archives of Pharmacology|January 19, 2010
Novel pharmacological approaches for antiarrhythmic therapyUrsula RavensCardiovascular Research|January 24, 2013
The new antiarrhythmic drug vernakalant: ex vivo study of human atrial tissue from sinus rhythm and chronic atrial fibrillationErich Wettwer, Torsten Christ, Sebastian Endig, et al.Canadian Journal of Physiology and Pharmacology|July 25, 2017
Atrial-selective K+ channel blockers: potential antiarrhythmic drugs in atrial fibrillation?Ursula RavensPageof 21